Cargando…

Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process()

INTRODUCTION: Despite the integration of Chinese medicine and biomedicine which has emerged in clinical practice worldwide, a comprehensive development process for clinical practice guidelines (CPG) has up to now been missing. A valid method for the rational use of predictions for herb-drug interact...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Nannan, Zhong, Linda L.D., Zhang, Chi, Han, Xuejie, Wang, Yuexi, Liu, Yuqi, Wang, Liying, Liu, Mengyu, Lu, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier GmbH. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102766/
https://www.ncbi.nlm.nih.gov/pubmed/32288885
http://dx.doi.org/10.1016/j.eujim.2016.11.013
_version_ 1783511904707149824
author Shi, Nannan
Zhong, Linda L.D.
Zhang, Chi
Han, Xuejie
Wang, Yuexi
Liu, Yuqi
Wang, Liying
Liu, Mengyu
Lu, Aiping
author_facet Shi, Nannan
Zhong, Linda L.D.
Zhang, Chi
Han, Xuejie
Wang, Yuexi
Liu, Yuqi
Wang, Liying
Liu, Mengyu
Lu, Aiping
author_sort Shi, Nannan
collection PubMed
description INTRODUCTION: Despite the integration of Chinese medicine and biomedicine which has emerged in clinical practice worldwide, a comprehensive development process for clinical practice guidelines (CPG) has up to now been missing. A valid method for the rational use of predictions for herb-drug interaction is a biggest challenge in guideline development process. METHODS: This article summarises the development process by reviewing key literature from CPG developers. It focuseson key methods and challenges specific to CPGs for integration by using text mining and bioinformatics to provide a powerful adjunct to CPG development. RESULTS: The guideline development process identified, together with new approaches, incorporates evidence-based methodology and provides better decisions through analysis of uncertain herb-drug interaction. CONCLUSIONS: This new process used three basic phases (preparation, development, and finalization) and seven steps providing a set of methodological principles for CPG development intergrating Chinese medicine and biomedicine.
format Online
Article
Text
id pubmed-7102766
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Published by Elsevier GmbH.
record_format MEDLINE/PubMed
spelling pubmed-71027662020-03-31 Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process() Shi, Nannan Zhong, Linda L.D. Zhang, Chi Han, Xuejie Wang, Yuexi Liu, Yuqi Wang, Liying Liu, Mengyu Lu, Aiping Eur J Integr Med Article INTRODUCTION: Despite the integration of Chinese medicine and biomedicine which has emerged in clinical practice worldwide, a comprehensive development process for clinical practice guidelines (CPG) has up to now been missing. A valid method for the rational use of predictions for herb-drug interaction is a biggest challenge in guideline development process. METHODS: This article summarises the development process by reviewing key literature from CPG developers. It focuseson key methods and challenges specific to CPGs for integration by using text mining and bioinformatics to provide a powerful adjunct to CPG development. RESULTS: The guideline development process identified, together with new approaches, incorporates evidence-based methodology and provides better decisions through analysis of uncertain herb-drug interaction. CONCLUSIONS: This new process used three basic phases (preparation, development, and finalization) and seven steps providing a set of methodological principles for CPG development intergrating Chinese medicine and biomedicine. Published by Elsevier GmbH. 2016-12 2016-11-30 /pmc/articles/PMC7102766/ /pubmed/32288885 http://dx.doi.org/10.1016/j.eujim.2016.11.013 Text en © 2016 Published by Elsevier GmbH. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Shi, Nannan
Zhong, Linda L.D.
Zhang, Chi
Han, Xuejie
Wang, Yuexi
Liu, Yuqi
Wang, Liying
Liu, Mengyu
Lu, Aiping
Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process()
title Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process()
title_full Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process()
title_fullStr Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process()
title_full_unstemmed Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process()
title_short Developing clinical practice guidelines for the integration of Chinese medicine and biomedicine: A new process()
title_sort developing clinical practice guidelines for the integration of chinese medicine and biomedicine: a new process()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102766/
https://www.ncbi.nlm.nih.gov/pubmed/32288885
http://dx.doi.org/10.1016/j.eujim.2016.11.013
work_keys_str_mv AT shinannan developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess
AT zhonglindald developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess
AT zhangchi developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess
AT hanxuejie developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess
AT wangyuexi developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess
AT liuyuqi developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess
AT wangliying developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess
AT liumengyu developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess
AT luaiping developingclinicalpracticeguidelinesfortheintegrationofchinesemedicineandbiomedicineanewprocess